Arphra/Issuer/UTHR

UTHR

United Therapeutics Corporation

HealthcareBiotechnologyUSUSD

$547.35

LiveJun 03, 2026

AI Brief

Market cap

$23.23B

52w range

272.12 – 609.35

P / E

—

EPS

—

Volume

118.35K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on United Therapeutics Corporation’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$2.47M

10 txns

Net flow

−$2.47M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$540.05

Change

+13.69%

Period high

$592.98

Period low

$473.12

Period start

$475.002026-02-02

Through 2026-06-02

Peers

No peer list available for UTHR.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+1.35%	-2.79%	-4.04%	+9.77%	+13.80%	+12.33%	+68.83%	+150.07%	+212.34%	+370.60%	+8882.15%

Aftermarket

Live

Jun 03, 05:28 PM

Last trade

$547.35

7 sh

Bid

$546.81

32 sh

Ask

$552.00

1 sh

Spread

$5.190

Sector & industry today

Live

Sectors

Healthcare
+1.68%
Energy
+1.35%
Financial Services
+1.22%
Industrials
+1.18%
Real Estate
+1.15%
Consumer Defensive
+0.74%
Consumer Cyclical
+0.42%
Basic Materials
+0.07%
Utilities
-0.56%
Communication Services
-2.21%
Technology
-2.26%

Top industries (issuer's industry highlighted)

Biotechnology
-1.55%
Investment - Banking & Investment Services
-4.83%
Broadcasting
-4.29%
Software - Infrastructure
-4.26%
Electronic Gaming & Multimedia
-3.95%
Software - Application
-3.91%
Computer Hardware
-3.62%
Internet Content & Information
-3.52%
Financial - Mortgages
-3.43%
Information Technology Services
-3.43%
Rental & Leasing Services
+3.42%
Auto - Recreational Vehicles
+3.21%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $636.83 (+16.35%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	56	$32.67K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	106	$60.6K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	240	$136.52K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	293	$167.92K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	400	$228.13K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	401	$230.05K	May 12, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin